You are here

  • Home
  • Archive
  • Volume 85, Issue 4
  • Pharmacodynamics and safety of lefradafiban, an oral platelet glycoprotein IIb/IIIa receptor antagonist, in patients with stable coronary artery disease undergoing elective angioplasty

Citation Tools

Article menu
Download PDFPDF
Interventional cardiology surgery
Pharmacodynamics and safety of lefradafiban, an oral platelet glycoprotein IIb/IIIa receptor antagonist, in patients with stable coronary artery disease undergoing elective angioplasty

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Akkerhuis KM, van den Brand MJBM, van der Zwaan C, et al
Pharmacodynamics and safety of lefradafiban, an oral platelet glycoprotein IIb/IIIa receptor antagonist, in patients with stable coronary artery disease undergoing elective angioplasty
Heart 2001;85:444-450.